检索

标题
作者
Advantages of switch to premixed insulin degludec/aspart in patients with type 2 diabetes mellitus who have not achieved an optimal control with previous insulin therapy
Elsukova O., Sobolev A.
POTENTIALS FOR THE DRUG CORRECTION OF SECONDARY MITOCHONDRIAL DYSFUNCTION IN PATIENTS WITH CORONARY ARTERY DISEASE AND COMORBID PATHOLOGY
Statsenko M., Turkina S., Tyshchenko I., Fabritskaya S., Poletaeva L.
SAFE AND EFFECTIVE COMBINATION OF ULTRALONG-ACTING BASAL INSULIN DEGLUDEC AND ULTRA-SHORT ACTING INSULINE ASPART IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS
Girsh Y., Veliyeva O.
Current approaches to therapy of type 2 diabetes mellitus in the era of new data on cardiovascular safety
Antsiferov M., Schernthaner G.
DIABETIC ANGIOPATHY «PAINFUL» POINTS: FOCUS ON HYPERTRIGLYCERIDEMIA AND FENOFIBRATE POTENTIAL
Rujatkina L., Rujatkin D., Zemljanuhina S.
10 let ispol'zovaniya pompovoy insulinoterapii v moskovskoy pediatricheskoy praktike -
Rybkina I., Petryaykina E., Koltunov I.
Effektivnost' trekhkomponentnoy terapii s ispol'zovaniem liraglutida (Viktoza) -pervogo analoga glyukagonopodobnogo peptida-1 dlitel'nogo deystviya - u patsientov s sakharnym diabetom 2 tipa i vistseral'nym ozhireniem
Antsiferov M., Koteshkova O.
Primenenie Aktovegina kak universal'nyy metod lecheniya oslozhneniy sakharnogo diabeta
Meleshkevich T., Luchina E., Lukashova M.
Statiny i risk vozniknoveniya novykh sluchaev sakharnogo diabeta: sootnoshenie riska i pol'zy. Sovremennye predstavleniya o tselevykh urovnyakh lipidov u patsientov s sakharnym diabetom
Shalaev S., Safiullina Z., Mikhal'chuk N.
PATOGENETIChESKIE PODKhODY K TERAPII DIABETIChESKOY POLINEVROPATII
Badalyan O., Savenkov A.
Preimushchestva novoy fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysbozhdeniya v terapii sakharnogo diabeta 2 tipa
Ametov A.
Effektivnyy i bezopasnyy kontrol' glikemii s pomoshch'yu Diabetona MV: zalog uspeshnoy profilaktiki khronicheskikh oslozhneniy sakharnogo diabeta 2 tipa
Biryukova E., Danilova T.
FARMAKOEKONOMIChESKIY ANALIZ PREIMUShchESTV KOMBINIROVANNOY INKRETINOVOY TERAPII BOL'NYKh SAKhARNYM DIABETOM 2 TIPA NA PRIMERE VILDAGLIPTINA
Arinina E., Rashid M., Antsiferov M.
Antiagregantnaya terapiya u patsientov s sakharnym diabetom, perenesshikh mozgovoy insul't
Matkevich E., Grapov D., Maksimov M.
Znachenie antioksidantnoy terapii v lechenii diabeticheskoy polinevropatii
Galstyan K.
Vliyanie ingibitorov dipeptidilpepti-dazy-4 na funktsional'noe sostoyanie miokarda u bol'nykh sakharnym diabetom 2 tipa
Ametov A., Kulidzhanyan N., Shurupova I., Trifonova T., Antsiferov M.
TIMELY ADMINISTRATION OF INSULIN THERAPY IN TYPE 2 DIABETES MELLITUS
Chernikova N., Prudnikova M., Chernikova N., Prudnikova M.
OSTEOPOROZ: TOChKA ZRENIYa ENDOKRINOLOGA
Biryukova E.
DIABETON MB IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS AND PREVENTION OF ITS LATE COMPLICATIONS
Kononenko I., Smirnova O., Smirnova O., Kononenko I.
PATHOGENETIC ASPECTS OF TREATMENT OF DISTAL PERIPHERAL POLYNEUROPATHY IN PATIENTS WITH DIABETES MELLITUS
Begma A., Begma I., Begma A., Begma I.
ASSESSMENT OF EFFICACY OF EDUCATION OF GENERAL PRACTITIONERS BY THE TRAINING PROGRAM FOR MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Yu Mayorov A., Surkova Y., Dedov I., Mayorov A., Surkova E., Dedov I.
ETIOPTHOGENIC ROLE OF INSULIN RESISTANCE IN THE DEVELOPMENT OF METABOLIC AND VASCULAR DISORDERS IN TYPE 2 DIABETES MELLITUS
Demidova T., Demidova T.
New possibilities for type 2 diabetes mellitus therapy. Results of a pilot observation program of efficacy and safety of the drug «Galvus» (vildagliptin) therapy in Moscow and in the regions of the Russian Federation
Pavlova M., Pavlova M.
Primenenie bazal'no-bolyusnogo rezhima insulinoterapii u bol'nykh sakharnym diabetom tipa 2
Antsiferov M., Morgunov L.
INNOVATsIONNYY KOMBINIROVANNYY PREPARAT GALVUS MET (VILDAGLIPTIN + METFORMIN) V LEChENII SAKhARNOGO DIABETA TIPA 2
Antsiferov M.
Bisoprolol in therapy of arterial hypertension and ischemic heart disease
Kirichenko A., Kirichenko A.
Experience of incritinomimetic exenatide (Byetta) use in the treatment of patients with type 2 diabetes mellitus with obesity
Antsiferov M., Koteshkova O., Sitnikov V., Mityaeva O., Pashintseva L., Budantseva T., Ivanova E., Anciferov M., Koteshkova O., Sitnikov V., Mityaeva O., Pashinceva L., Budanceva T., Ivanova E.
Features of the pathogenesis and treatment of diabetes mellitus during the COVID-19 pandemic
Bagriy A., Mikhailichenko E., Prikolota A., Mogilevskaya K.
Problem of treatment adherence in patients with type 2 diabetes mellitus
Akulova A., Zhulina Y., Rozhkova V., Martynova E., Poteshkin Y.
Is non-alcoholic fatty liver disease a consequence of obesity and a predictor of diabetes?
Volkova N., Panenko S., Golubeva A.
Testosterone replacement therapy in men with type 2 diabetes mellitus and neuropathy
Zelenina T., Salukhov V., Zemlyanoy A., Chebykina O.
The use of fixed ratio combination of insulin glargine and lixisenatide in patients with type 2 diabetes mellitus in real clinical practice. Own clinical experience
Khamnueva L., Andreeva L., Davydova A., Chugunova E., Tokareva N., Molodtsova N.
Modern approaches to using the FreeStyle Libre Flash glucose monitoring system
Demidov N., Koteshkova O., Antsiferov M.
Modern approaches to the choice of hypoglycemic therapy in patients with type 2 diabetes mellitus: a niche of DPP-4 inhibitors
Chernikova N., Knyshenko O.
Extreme risk category in the stratification of cardiovascular complications. Consensus Council of experts
Expert C.
Experience of the use of insulin degludec in the treatment of patients with type 1 diabetes mellitus (according to the data of the Moscow segment of the Federal Diabetes Register)
Demidov N., Mishra O., Antsiferov M.
Adiponectin and metabolic parameters in patients with type 2 diabetes mellitus and hypothyroidism
Verbovoy A., Lomonova T., Sharonova L.
ASSESSMENT OF THE EFFICACY AND SAFETY OF INSULIN DEGLUDEC IN CHILDREN AND ADOLESCENTS WITH TYPE 1 DIABETES MELLITUS IN REAL-LIFE CLINICAL PRACTICE
Kiyaev A., Kondrashova O., Chernykh L., Pollyak O., Yusupova A., Slovak M., Zaykova I.
Effect of SGLT-2 inhibitors on cardiovascular outcomes: review of results of CVD-REAL trial
Antsiferov M.
THE USE OF ANTIBACTERIAL DRUGS DURING ORTHOPAEDIC ALIGNMENT WITH REMOVABLE LAMINAR DENTURES IN PATIENTS WITH TYPE 2 DIABETES MELLITUS TAKING INTO ACCOUNT THE RESULTS OF PCR-BASED DIAGNOSTICS
Shevkunova N.
Features of use of dapagliflozin in thetreatment of patients with type 2 diabetes mellitus
Antsiferov M.
OVERVIEW OF PHARMACOECONOMIC STUDIES OF INSULIN PUMP THERAPY IN DIABETES MELLITUS
Tolkushin A.
GLYCEMIC VARIABILITY AS A THERAPEUTIC TARGET IN THE TREATMENT OF PATIENTS WITH TYPE 2 DIABETES MELLITUS
Ametov A., Chernikova N., Demidova T., Nazhmutdinova P.
Sakharosnizhayushchiy effekt flozinov po sravneniyu s preparatami sul'fonilmocheviny u patsientov s sakharnym diabetom 2 tipa
Galstyan G.
Preimushchestva fiksirovannoy kombinatsii saksagliptina i metformina modifitsirovannogo vysvobozhdeniya (Kombogliz Prolong) v terapii SD 2 tipa
Ametov A.
Primenenie kombinirovannoy terapii glimepiridom i metforminom u patsientov s sakharnym diabetom 2 tipa. Rezul'taty Rossiyskogo observatsionnogo issledovaniya
Zaytseva N., Shamkhalova M.
Ispol'zovanie preparatov, proizvedennykh po novym tekhnologiyam, v lechenii nealkogol'nogo steatogepatita
Kazyulin A., Babina S.
VOZMOZhNOSTI DIBIKORA V KORREKTsII METABOLIChESKIKh I SOSUDISTYKh NARUShENIY U BOL'NYKh KhRONIChESKOY SERDEChNOY NEDOSTATOChNOST'Yu I SAKhARNYM DIABETOM 2 TIPA
Statsenko M., Vinnikova A., Shilina N., Ronskaya A.
Farmakoterapiya diabeticheskoy nevropatii: chto eshche krome kontrolya glikemii?
Biryukova E., Danilova T.
Preparaty tioktovoy kisloty v lechenii erektil'noy disfunktsii u bol'nykh sakharnym diabetom
Kurnikova I.
SODERZhANIE VITAMINA D 3 I POKAZATELI METABOLIZMA KOSTNOY TKANI U ZhENShchIN S SAKhARNYM DIABETOM 2 TIPA
Verbovoy A., Sharonova L., Verbovaya N., Demidova D., Kapishnikov A.
Diabeticheskaya retinopatiya i makulyarnyy otek. Algoritmy diagnostiki i lecheniya klinicheski znachimykh form
Shadrichev F.
Rannee naznachenie insulina glargin patsientam s sakharnym diabetom 2 tipa, prediabetom i vysokim serdechno-sosudistym riskom: rezul'taty issledovaniya ORIGIN
Antsiferov M., Biryukova E., Zilov A.
Farmakoterapiya, mestnye i dopolnitel'nye metody lecheniya pri sindrome diabeticheskoy stopy
Obolenskiy V., Nikitin V., Leval' P., Ermolova D., Molochnikov A., Ermolov A.
SUSTAINED-RELEASE METFORMIN (GLUCOPHAGE LONG) IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Nikonova T., Nikonova T.
EVALUATION OF THE CLINICAL AND ECONOMIC EFFICIENCY OF PHARMACOTHERAPY OF DIABETIC POLYNEUROPATHY
Matveev N., Matveev N.
APPROACHES TO THE TREATMENT OF DIABETES MELLITUS IN ELDERLY PATIENTS: POTENTIALS FOR USE OF INSULIN NOVOMIX 30
Surkova E., Surkova E.
CLINICAL ASPECTS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN COMBINATION WITH METFORMIN: BENEFITS FOR DIFFERENT GROUPS OF PATIENTS
Antsiferov M., Antsiferov M.
POSSIBILITY OF CORRECTION OF OXIDATIVE STRESS IN PATIENTS WITH DIABETES USING DIBICOR
Zanozina O., Zanozina O.
POTENTIALS FOR USE OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS IN TYPE 2 DIABETES MELLITUS: INITIATION AND CONTINUATION OF THERAPY
Antsiferov M., Zilov A., Antsiferov M., Zilov A.
Innovative approaches to the treatment of type 2 diabetes mellitus: the role of specialized product for enteral nutrition "Glucerna SR"
Sharafetdinov K., Plotnikova O., Sharafetdinov K., Plotnikova O.
Polinevropatii v terapevticheskoy praktike
Erofeeva S.
DIABETIChESKAYa PERIFERIChESKAYa POLINEVROPATIYa: SOVREMENNYE PREDSTAVLENIYa O PATOGENEZE I PODKhODY K TERAPII
Komelyagina E., Antsiferov M.
The effectiveness of the drug Vessel Due F in patients with diabetes with nonproliferative and preproliferative diabetic retinopathy
Ishchenko I., Milen'kaya T., Ischenko I., Milenkaya T.
Prospects of the first human glucagon-like peptide 1 analog liraglutid use in the treatment of patients with type 2 diabetes mellitus
Antsiferov M., Dorofeeva L., Anciferov M., Dorofeeva L.
Diabetic neuropathy: pathophysiological mechanisms and metabolic therapy
Kurnikova I.
Possibilities of using trimetazidine in comorbid cardiovascular pathology and metabolic disorders
Nikiforov V.
Multiple thyroid carcinoma and other long-term endocrine consequences of chemoradiotherapy for medulloblastoma: a clinical case
Khruleva Y., Amergulov I., Likhodey N., Dzyuba A., Sych Y., Pavlova M.
Dermatoses in elderly diabetic patients
Ladygina D., Zheleznyakova A.
Insulin resistance - a common enemy for endocrinologists and cardiologists
Verbovoy A., Dolgikh Y.
The use of collagen plates in orthopedic dental rehabilitation of patients with drug-compensated diabetes mellitus
Shevkunova N., Vorobyov M., Gushchin V.
Resolution on the results of the expert panel «IDegLira: is it 1 + 1 or anything more?»
Antsiferov M., Galstyan G.
Clinical features of skin lesions in patients with diabetes mellitus
Svechnikova E., Lykova S., Nemchaninova O., Morzhanaeva M.
The role of vitamin D in preventing pregnancy complications in gestational diabetes mellitus
Kyazimova A., Abdullaeva R., Polukhova S., Babaeva S.
Obesity and associated diseases. Modern possibilities of prevention and treatment in real clinical practice
Markova T.
The first results of an observational retrospective study assessing the effectiveness of the use dapagliflozin in patients with type 2 diabetes mellitus in real clinical practice in the Russian Federation (GLORIA study)
Antsiferov M., Kvasnikov B.
Initiation of insulin therapy in patients with type 2 diabetes mellitus according to the Federal Diabetes Register in Moscow
Demidov N., Mishra O., Safronov T., Antsiferov M.
NEW POSSIBILITIES OF CARDIOVASCULAR RISK MANAGEMENT IN PATIENTS WITH TYPE 2 DIABETES MELLITUS
Verbovoy A., Pashentseva A., Verbovaya N., Kosareva O.
The use of insulin glargine 300 lU/ml (Toujeo SoloStar®) in real clinical practice
Antsiferov M.
CURRENT POSSIBILITIES OF COMBINED THERAPY IN THE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Chemikova N.
Advantages of the use of insulin aspart in insulin pump therapy in type 1 diabetic patients
Kovrigina E., Tyulganova V.
POTENTIALS FOR THE IMPROVEMENT OF TREATMENT OF PATIENTS WITH TYPE 1 DIABETES MELLITUS USING HUMAN ULTRA-LONG INSULIN ANALOGUE DEGLUDEC IN OUTPATIENT SETTINGS
Kalashnikova M., Zilov A., Yazykova D., Likhodey N., Fadeev V.
ASSESSMENT OF LIVER FIBROSIS IN PATIENTS WITH DIABETES MELLITUS
Bakulin I., Vinnytskaya E., Sandler Y., Keiyan V., Rodionova S.
SVYaZ' MIKROBNOGO PEYZAZhA KIShEChNIKA S METABOLIChESKIM SINDROMOM
Plotnikova E., Krasnov O.
Preimushchestva svoevremennoy initsiatsii insulinoterapii. Rezul'taty rossiyskoy observatsionnoy programmy HUBIN
Chernikova N., Ivanova L., Abaeva F.
Effektivnost' i bezopasnost' primeneniya dvukhfaznogo analoga insulina NovoMiks 30 pri sakharnom diabete 2 tipa: ot klinicheskikh issledovaniy do real'noy praktiki
Surkova E.
Sakharnyy diabet i osteoporoz. Analiz kombinirovannogo podkhoda k lecheniyu
Doskina E.
METFORMIN - NADEZhNYY PARTNER V LEChENII PATsIENTOV S SAKhARNYM DIABETOM 2 TIPA
Petunina N., Kuzina I.
Osobennosti vedeniya patsientov s arterial'noy gipertenziey i sakharnym diabetom 2 tipa: vzglyad kardiologa
Statsenko M., Derevyanchenko M.
Rannyaya diagnostika i lechenie narushennoy glikemii natoshchak zamedlyaet tempy ee konversii v narushennuyu tolerantnost' k glyukoze i sakharnyy diabet 2 tipa
Demidova I., Boeva V.
INNOVATsIONNAYa SAKhAROSNIZhAYuShchAYa TERAPIYa: NOVAYa STRATEGIYa DLYa STAROY PROBLEMY
Antsiferov M., Schemthaner G., Ametov A.
Opyt ispol'zovaniya novoy formy gliklazida MV 60 mg (Diabeton MV 60 mg) v terapii bol'nykh sakharnym diabetom 2 tipa
Antsiferov M., Dorofeeva L.
Ratsional'naya farmakoterapiya SD 2 tipa: primenenie ingibitora DPP-4 saksagliptina i metformina v klinicheskoy praktike
Ametov A., Brashchenkova A.
METABOLIChESKIE POKAZATELI U MUZhChIN S SAKhARNYM DIABETOM 2 TIPA I IShEMIChESKOY BOLEZN'Yu SERDTsA
Verbovoy A., Vorozhtsova E., Orlova T.
HOW TO EFFECTIVELY MANAGE TWO MAJOR DEFECTS IN TYPE 2 DIABETES MELLITUS?
Biryukova E., Antsiferov M., Biryukova Y., Antsiferov M.
Hypoglycaemia in pregnant women with type 1 diabetes mellitus
Arbatskaya N., Tisel'ko A., Ignatova N., Arbatskaya N., Tiselko A., Ignatova N.
SAXAGLIPTIN (ONGLYZA ®) IN CONCEPTION OF EFFECTIVE MANAGEMENT OF TYPE 2 DIABETES MELLITUS
Petunina N., Brashchenkova A., Petunina N., Brashcenkova A.
CURRENT APPROACHES TO THERAPY TYPE 2 DIABETES - EFFECT ON INSULIN RESISTANCE
Shishkova V., Shishkova V.
PHARMACOECONOMIC ASPECTS OF USE OF SULFONYLUREA MEDICATIONS IN INSULIN-INDEPENDENT DIABETES
Rudakova A., Rudakova A.
AUTONOMIC NEUROPATHY IN DIABETES MELLITUS: CLINICAL MANIFESTATIONS, DIAGNOSIS AND TREATMENT
Barinov A., Novosadova M., Barinov A., Novosadova M.
201 - 300 的 343 信息 << < 1 2 3 4 > >> 

检索提示:

  • 检索的名词区分大小写
  • 常用字词将被忽略
  • 默认情况下只有在查询结果满足所有检索词才返回(例如,隐含AND)
  • 使用OR结合多个检索词,便于查找含有这些检索词的文章,例如education OR research
  • 使用括号来创建更复杂的查询; 例如:archive ((journal OR conference) NOT theses)
  • 使用引号检索一个完整的词组; 例如: "open access publishing"
  • 使用-或者NOT排除一个检索词; 例如:online -politics or online NOT politics
  • 在检索词里使用 *作为通配符匹配任何字符序列; 例如., soci* morality 将符合含有 "sociological" or "societal"的词语
##common.cookie##